The hasty and reckless decision by most European states, including Italy, to suspend the AstraZeneca vaccine is fueling a series of retro-thoughts and interpretations that try to explain how such a measure could have been achieved. Since the cases of adverse effects are so rare and not even proven, the reason – or the real reason – that pushed states to such a ban must be another. And the thought obviously went to a kind of “conspiracy” within Big Pharma, or rather a disinformation war between competing pharmaceutical companies to conquer a larger slice of the vaccine market. From this point of view, AstraZeneca would be the company to be killed because it produces an excellent vaccine that is the cheapest (2-3 dollars per dose, compared to 15-20 dollars for Pfizer and Moderna). In the past, the Italian patron of Irbm, who collaborates with AstraZeneca, has also made it clear that many problems could derive from this element: “I suspect this vaccine is annoying because it is too cheap“. In reality this is not the case.
Subscribe to continue reading
Are you already a subscriber? Log in Stay informed wherever you are thanks to our digital offer
The inquiries, the editorials, the newsletters. The major current events on the devices you prefer, daily insights from Italy and the world
The web sheet at € 8.00 for one month Discover all the solutions